Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Solid Compositions Comprising A Glp 1 Agonist And A Salt Of N (8 (2 Hydroxybenzoyl)amino)caprylic Acid
Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
25 November 2020
Publication Number
49/2020
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2022-04-29
Renewal Date
Applicants
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd
Inventors
1. BJERREGAARD, Simon
Novo Allè
2880 Bagsværd
2. LYTT, RAHBEK, Ulrik
Novo Allè
2880 Bagsværd
3. JONAS, SASSENE, Philip
Novo Allè
2880 Bagsværd
4. JEROEN, WATER, Jorrit
Novo Allè
2880 Bagsværd
5. VEGGE, Andreas
Novo Allè
2880 Bagsværd
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202047051330-STATEMENT OF UNDERTAKING (FORM 3) [25-11-2020(online)].pdf | 2020-11-25 |
| 2 | 202047051330-SEQUENCE LISTING(PDF) [25-11-2020(online)].pdf | 2020-11-25 |
| 3 | 202047051330-SEQUENCE LISTING [25-11-2020(online)].txt | 2020-11-25 |
| 4 | 202047051330-PRIORITY DOCUMENTS [25-11-2020(online)].pdf | 2020-11-25 |
| 5 | 202047051330-POWER OF AUTHORITY [25-11-2020(online)].pdf | 2020-11-25 |
| 6 | 202047051330-FORM 1 [25-11-2020(online)].pdf | 2020-11-25 |
| 7 | 202047051330-DRAWINGS [25-11-2020(online)].pdf | 2020-11-25 |
| 8 | 202047051330-DECLARATION OF INVENTORSHIP (FORM 5) [25-11-2020(online)].pdf | 2020-11-25 |
| 9 | 202047051330-COMPLETE SPECIFICATION [25-11-2020(online)].pdf | 2020-11-25 |
| 10 | 202047051330-FORM 18 [26-11-2020(online)].pdf | 2020-11-26 |
| 11 | 202047051330-Proof of Right [08-12-2020(online)].pdf | 2020-12-08 |
| 12 | 202047051330-FORM 3 [24-05-2021(online)].pdf | 2021-05-24 |
| 13 | 202047051330.pdf | 2021-10-18 |
| 14 | 202047051330-FER.pdf | 2021-10-18 |
| 15 | 202047051330-Information under section 8(2) [10-11-2021(online)].pdf | 2021-11-10 |
| 16 | 202047051330-FORM 3 [10-11-2021(online)].pdf | 2021-11-10 |
| 17 | 202047051330-FER_SER_REPLY [15-12-2021(online)].pdf | 2021-12-15 |
| 18 | 202047051330-CLAIMS [15-12-2021(online)].pdf | 2021-12-15 |
| 19 | 202047051330-US(14)-HearingNotice-(HearingDate-09-02-2022).pdf | 2022-01-04 |
| 20 | 202047051330-Correspondence to notify the Controller [02-02-2022(online)].pdf | 2022-02-02 |
| 21 | 202047051330-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [04-02-2022(online)].pdf | 2022-02-04 |
| 22 | 202047051330-US(14)-ExtendedHearingNotice-(HearingDate-09-03-2022).pdf | 2022-02-07 |
| 23 | 202047051330-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [01-03-2022(online)].pdf | 2022-03-01 |
| 24 | 202047051330-US(14)-ExtendedHearingNotice-(HearingDate-13-04-2022).pdf | 2022-03-08 |
| 25 | 202047051330-Correspondence to notify the Controller [06-04-2022(online)].pdf | 2022-04-06 |
| 26 | 202047051330-Information under section 8(2) [14-04-2022(online)].pdf | 2022-04-14 |
| 27 | 202047051330-FORM 3 [14-04-2022(online)].pdf | 2022-04-14 |
| 28 | 202047051330-Written submissions and relevant documents [27-04-2022(online)].pdf | 2022-04-27 |
| 29 | 202047051330-Annexure [27-04-2022(online)].pdf | 2022-04-27 |
| 30 | 202047051330-PatentCertificate29-04-2022.pdf | 2022-04-29 |
| 31 | 202047051330-IntimationOfGrant29-04-2022.pdf | 2022-04-29 |
| 32 | 202047051330-PROOF OF ALTERATION [21-12-2022(online)].pdf | 2022-12-21 |
| 33 | 202047051330-FORM-26 [12-01-2023(online)].pdf | 2023-01-12 |
| 34 | 202047051330-RELEVANT DOCUMENTS [15-09-2023(online)].pdf | 2023-09-15 |
| 35 | 202047051330-FORM-26 [28-12-2023(online)].pdf | 2023-12-28 |
| 36 | 202047051330-CERTIFIED COPIES-CERTIFICATE U-S 72 147 & UR 133-2 [14-04-2025(online)].pdf | 2025-04-14 |
Search Strategy
| 1 | 2021-06-0712-44-24E_07-06-2021.pdf |